Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caffeine as a potential indicator for acetylator status.

R B Rankin1, S A Hudson, A F Fell

  • 1Department of Pharmacy, Bangour General Hospital, West Lothian, U.K.

Journal of Clinical Pharmacy and Therapeutics
|February 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping bark bacteria: initial insights of stemflow-induced changes in bark surface phyla.

Microbiology spectrum·2023
Same author

Combined active and passive heat exposure induced heat acclimation in a soccer referee before 2014 FIFA World Cup.

SpringerPlus·2016
Same author

Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils.

Allergy·2008
Same author

High-resolution method for regulatory control of Echinacea species in Nutraceuticals by CD-MEKC.

Journal of pharmaceutical and biomedical analysis·2005
Same author

Mental incapacity and medical ethics.

The British journal of psychiatry : the journal of mental science·2004
Same author

Evaluation of the implementation of a local treatment guideline in secondary prevention post-myocardial infarction.

Pharmacy world & science : PWS·2001
Same journal

Impact of pharmacist-initiated educational interventions on improving medication reconciliation practice in geriatric inpatients during hospital admission in Vietnam.

Journal of clinical pharmacy and therapeutics·2022
Same journal

Evaluation of off-label anti-vascular endothelial growth factor and steroid implant medication uses in macular edema due to retinal vein occlusion in Turkey.

Journal of clinical pharmacy and therapeutics·2022
Same journal

A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.

Journal of clinical pharmacy and therapeutics·2022
Same journal

Effects of caregiver counselling on medication persistence and adherence in patients with dementia at a pharmacist-managed clinic: A pilot study.

Journal of clinical pharmacy and therapeutics·2022
Same journal

The 50% and 95% effective doses of remimazolam tosilate with adjuvant sufentanil for sedation in patients with liver cirrhosis undergoing oesophagogastric varices screening endoscopy.

Journal of clinical pharmacy and therapeutics·2022
Same journal

Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study.

Journal of clinical pharmacy and therapeutics·2022
See all related articles

The caffeine acetylation test accurately identifies

Area of Science:

  • Pharmacogenetics
  • Drug Metabolism
  • Clinical Chemistry

Background:

  • Patient acetylation status (fast or slow) is crucial for clinical practice, aiding in toxicity risk assessment and N-acetylated drug dosage.
  • Accurate determination of acetylation phenotype is essential for personalized medicine and optimizing drug therapy.
  • N-acetylation is a key metabolic pathway influencing drug efficacy and safety.

Purpose of the Study:

  • To evaluate the caffeine test as a reliable marker for assessing human drug acetylation capacity.
  • To compare the caffeine test's results with the established sulphadimidine test for acetylator phenotyping.
  • To investigate potential interference of co-administered N-acetylated drugs on caffeine metabolite ratios.

Main Methods:

  • Utilized high-performance liquid chromatography (HPLC) to quantify urinary metabolites: 5-acetylamino-6-formylamino-3-methyl uracil (AFMU) and 1-methylxanthine (MX).

Related Experiment Videos

  • Determined the AFMU:MX ratio in 26 subjects to classify them as 'slow' or 'fast' acetylators.
  • Compared caffeine test results with those obtained using sulphadimidine as a reference substance.

    • Main Results:

    • The caffeine test successfully assigned subjects to 'slow' (AFMU:MX < 2.1) and 'fast' (AFMU:MX > 2.3) acetylator phenotypes.
    • Results from the caffeine test showed high accordance with the sulphadimidine test, with only one subject discrepancy.
    • Concurrent administration of sulphadimidine caused a small, but potentially clinically significant, interference (11% mean bias) in caffeine metabolite ratios.

    Conclusions:

    • The caffeine test, based on urinary AFMU:MX ratios, is a viable and accurate method for determining acetylator status.
    • The caffeine test demonstrates good concordance with the sulphadimidine test, supporting its clinical utility.
    • Potential interference from co-administered N-acetylated drugs necessitates careful consideration in clinical application of the caffeine test.